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Intestine is a major target of vitamin D and several studies indicate an associ-
ation between vitamin D deficiency and inflammatory bowel diseases (IBD),
but also increased colorectal cancer (CRC) risk and mortality. However, the
putative effects of 1a,25-dihydroxyvitamin D3 (calcitriol), the active vitamin
D metabolite, on human colonic stem cells are unknown. Here we show by
immunohistochemistry and RNAscope in situ hybridization that vitamin D
receptor (VDR) is unexpectedly expressed in LGR5+ colon stem cells in
human tissue and in normal and tumor organoid cultures generated from
patient biopsies. Interestingly, normal and tumor organoids respond differen-
tially to calcitriol with profound and contrasting changes in their transcrip-
tomic profiles. In normal organoids, calcitriol upregulates stemness-related
genes, such as LGR5, SMOC2, LRIG1, MSI1, PTK7, and MEX3A, and inhi-
bits cell proliferation. In contrast, in tumor organoids calcitriol has little
effect on stemness-related genes while it induces a differentiated phenotype,
and variably reduces cell proliferation. Concordantly, electron microscopy
showed that calcitriol does not affect the blastic undifferentiated cell pheno-
type in normal organoids but it induces a series of differentiated features in
tumor organoids. Our results constitute the first demonstration of a regula-
tory role of vitamin D on human colon stem cells, indicating a homeostatic
effect on colon epithelium with relevant implications in IBD and CRC.
Abbreviations
ChIP, chromatin immunoprecipitation; CRC, colorectal cancer; EGF, epidermal growth factor; FBS, fetal bovine serum; GSEA, gene set
enrichment analysis; IBD, inflammatory bowel diseases; IGV, integrative genome visualization; PBS, phosphate-buffered saline; PGE2,
prostaglandin E2; RSPO1, R-spondin 1; VDR, vitamin D receptor.
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Introduction
Calcitriol (1a,25-dihydroxyvitamin D3) is the active
vitamin D metabolite and a main regulator of the
physiology and homeostasis of the intestine. It induces
Ca2+ and phosphate absorption, and contributes to
epithelial integrity/barrier function, detoxification, and
protection against infection [1]. These actions of cal-
citriol are the consequence of it binding to and activat-
ing vitamin D receptor (VDR), a member of the
nuclear receptor superfamily that acts predominantly
as a transcription factor modulating the expression of
a high number of genes in a tissue- and cell-dependent
fashion [2,3]. Epidemiological and preclinical studies
suggest an association between vitamin D deficiency
and inflammatory bowel diseases (IBD), various
extraskeletal disorders, and several neoplasias, particu-
larly colorectal cancer (CRC) [1,3,4]. Supporting this,
experimental results in immortal carcinoma cell lines
and animal models of CRC demonstrate a multilevel
protective action of calcitriol and other VDR agonists
[3,5].
High level of Vdr RNA has been found in the small
and large intestine/colon as compared to other mouse
tissues [6]. VDR was reported to be preferentially
expressed in top differentiated enterocytes, which sup-
ports its role in Ca2+ and phosphate absorption and
barrier function, and to a lesser extent in cells at the
crypt base [7,8]. However, a detailed analysis of VDR
protein expression and function in human colon tissue
is lacking. Intestinal epithelium is the highest renewal
body tissue, which has hampered its long-term cell cul-
ture in vitro. However, the identification of LGR5 as a
marker of colon crypt bottom stem cells [9] made pos-
sible their isolation and unlimited growth as three-di-
mensional culture, forming structures called organoids
or mini-guts [10,11]. Organoid technology is a power-
ful tool for multiple applications (diagnosis, personal-
ized medicine. . .) and has now allowed us to study
VDR expression and calcitriol action in human colon
stem cells using CRC patient-derived organoids.
Here, we combined RNAscope in situ hybridization
and immunohistochemistry to study the expression of
LGR5 stem cell marker and VDR protein in human
colon mucosa. Interestingly, our results show for the
first time that a high proportion of crypt bottom stem
cells co-express LGR5 and VDR. This led us to investi-
gate the role of calcitriol in colon stem cells. To this
end, we generated a unique living biobank of CRC
patient-derived organoids from matched healthy (nor-
mal) and tumor colon biopsies. Remarkably, matched
normal and tumor organoids responded distinctly to
calcitriol, which has contrasting effects on cell
phenotype and gene expression. Our results strongly
support a major regulatory role of vitamin D on
human colon normal and cancer stem cells that has
potential implications in important medical conditions
such as IBD and CRC.
Results
VDR is expressed in human colon crypt stem
cells
To analyze the expression of VDR protein in human
colon mucosa, we performed immunohistochemistry
assays in healthy tissue from CRC patients. In the
same sections, to identify the colon stem cells, we car-
ried out RNAscope in situ hybridization for detection
of the stem marker LGR5 [9] as all available anti-
LGR5 antibodies showed a lack of specificity in test
experiments (data not shown). We observed a strong
predominantly nuclear VDR signal in both top differ-
entiated enterocytes/cells and a population of cells
located at the crypt bottom, while those in the mid-
crypt displayed a lower signal (Figs 1A and S1). Quan-
tification of data at cell level in 100 crypts from four
CRC patients (25 crypts/patient) revealed that VDR is
expressed in 64% of crypt bottom cells and that 87%
of LGR5+ cells were positive for VDR expression
(Fig. 1B). We additionally performed double
immunostaining of tissue microarrays of healthy colon
from 25 CRC patients with antibodies against VDR
and PTK7, a stemness-related cell marker [12]. In line
with LGR5 data, VDR (nuclear) and PTK7 (extranu-
clear) proteins were largely co-expressed in crypt bot-
tom cells (Fig. S1). These findings provide evidence,
for the first time, that VDR is expressed in human
colon stem cells in vivo.
Human normal and tumor colon organoids
express VDR and respond to calcitriol
To investigate the effect of vitamin D on human colon
stem cells, we successfully generated a living biobank
of long-term normal and tumor organoid cultures
from 39 CRC patients who had undergone surgery for
curative purposes (Table S1). Normal organoids had
relatively homogeneous cystic morphology formed by
one or two cell layers, whereas tumor organoids were
frequently multilayered and showed two alternative
morphologies, cystic or compact (Fig. 1C) and resem-
bled the primary tumor morphology (Fig. 1D). The
analysis by RT-qPCR of VDR RNA expression
revealed slightly higher levels in normal than in tumor
organoids (Fig. 2A). RNA expression of CYP24A1,
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Fig. 1. Human colon stem cells express VDR. (A) Images of VDR immunofluorescence (red) and LGR5 RNAscope in situ hybridization
(green) in human colon crypts. Scale bars: 50 lm left and 20 lm right. (B) Quantification of VDR and LGR5-positive cells in 25 crypts/patient
(n = 4 patients). Bars represent mean  standard error of the mean (SEM). (C) Representative phase-contrast images of normal and tumor
colon organoids. Scale bars: 500 lm. (D) Hematoxylin/eosin images showing the primary tumor architecture and tumor organoid phenotype.
Scale bars: 100 lm.
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the most responsive calcitriol-target gene that encodes
the enzyme responsible for its degradation, was higher
in tumor than in normal organoids, as occurs in tumor
vs. healthy colon tissue [13]. Calcitriol treatment
increased CYP24A1 RNA to comparable levels in the
two types of organoids (Fig. 2B). In addition, calcitriol
increased both VDR and CYP24A1 proteins to a vari-
able extent in matched normal and tumor organoids
from a subset of patients (Fig. 2C) and CA2, a protein
typically expressed in normal colon organoids [14]
(Fig. 2C). We also performed RNAscope in situ
hybridization for LGR5 detection in organoids and, as
in colon tissue, VDR protein and LGR5 RNA were
mostly co-expressed in normal and tumor organoids.
VDR signal was increased by calcitriol in both types
of organoids whereas that of LGR5 seemed to increase
apparently only in normal organoids (Fig. 2D). Alto-
gether, these results showed that both types of orga-
noids, derived respectively from human normal and
cancer stem cells, express VDR and respond to cal-
citriol.
Calcitriol differentially modulates cell phenotype
and proliferation in normal and tumor colon
organoids
Based on the induction of differentiation by calcitriol
on carcinoma cell lines [15], we next explored the effect
of this hormonal agent on the cell phenotype in both
types of organoids. Ultrastructural analysis of
untreated normal organoids from three patients consis-
tently showed an undifferentiated cell phenotype with
decondensed euchromatin and large nucleoli typical of
high transcriptional activity, absence of intercellular
adhesion structures and microvilli, many free ribo-
somes, and few Golgi complexes and intermediate fila-
ment bundles. Unexpectedly, calcitriol treatment did
not change the undifferentiated cell phenotype in nor-
mal organoids (Fig. 3A, upper panels). On the con-
trary, cells of three tumor organoid cultures that
showed a similar undifferentiated phenotype responded
to calcitriol with changes compatible with
differentiation: heterochromatin patches, prominent
microvilli and adhesion structures (desmosomes)
(Fig. 3A, lower panels), bundles of intermediate fila-
ments, abundant, well-developed, rough endoplasmic
reticulum cisternae, autophagic vacuoles, and Golgi
complexes (Fig. 3B).
We then explored whether the antiproliferative effect
of calcitriol reported in carcinoma cell lines [2,3] was
reproduced in colon organoids. Calcitriol consistently
diminished cell proliferation in all seven patient-
derived normal organoids under study and, to a vari-
able extent, in tumor organoids (Fig. 4A,B). No differ-
ences were found in the number of organoids, which
suggests that calcitriol does not affect the clonogenicity
of either normal or cancer stem cells (Fig. 4C). Taken
together, the VDR RNA level in normal and tumor
organoids show a statistically significant correlation
with the antiproliferative response to calcitriol
(Fig. 4D,E), which may also depend on other cal-
citriol-related features and/or the tumor-specific muta-
tional status. Together, these results indicate that
calcitriol contributes to maintain the undifferentiated
phenotype and restricts the proliferation of normal
colon stem cells and their progeny, while it induces dif-
ferentiation and variably inhibits the proliferation of
cancer stem cells.
Calcitriol differentially regulates the expression
of stemness, differentiation, proliferation and
tumorigenesis genes in colon cancer patient-
derived normal and tumor organoids
Next we studied the long-term effect of calcitriol on
the transcriptomic profiles of six matched normal and
tumor organoid cultures by RNA-seq analysis upon
96 h of treatment. Given the differences in function
and mutational profiles between colon segments (right-
side, left-side) [16,17], to attenuate interindividual vari-
ability [18], we selected patients with left-side colon
(descending plus sigma) tumors (Table S1). Mutational
analysis of tumor organoids confirmed that they har-
bored patterns of genetic alterations that are typical of
Fig. 2. Human colon patient-derived normal and tumor organoids express VDR and respond to calcitriol. (A) Box-plot of VDR RNA level in 18
normal and 9 tumor organoid cultures in relation to that of SW480-ADH colon cancer cells. Box plots represent median  max/min.
Statistical analysis was performed by nonparametric Mann–Whitney test, *P < 0.05. (B) Box-plot of CYP24A1 RNA level in relation to that of
SW480-ADH colon cancer cells (left) and its fold-change (right) in the organoid cultures used in (A) treated for 96 h with 100 nM calcitriol or
vehicle. Box plots represent median  max/min. Statistical analysis was performed by nonparametric Kruskal–Wallis test using the
Benjamini, Krieger and Yekutieli post test (left) and Mann–Whitney test (right), *P < 0.05, ***P < 0.001. (C) Western blot analysis of VDR,
CYP24A1, and CA2 protein levels in whole-cell extracts from six matched normal and tumor organoid cultures treated for 96 h with 100 nM
calcitriol or vehicle. b-actin was used as a loading control. The graphics below show the VDR/b-actin ratio. (D) Images of VDR
immunofluorescence (red) and LGR5 RNAscope in situ hybridization (green) in human normal and tumor organoids treated for 96 h with
100 nM calcitriol or vehicle. Scale bars: 15 lm.
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Fig. 3. Calcitriol induces cell differentiation in human tumor organoids. (A) Representative ultrastructural images of normal (patient #11) and
tumor organoids (patient #38) treated with 100 nM calcitriol or vehicle for 96 h. Upper panel scale bars (from left to right): 2 lm, 2 lm,
2 lm, and 1 lm. Lower panel scale bars: 2 lm, 1 lm, 2 lm, and 1 lm. L, lumen; asterisks, heterochromatin aggregates; arrowheads,
desmosomes; red-dotted line, intercellular region lacking mature adhesion structures. (B) Epithelial differentiation features induced by
calcitriol in tumor organoids from patients #4 and #29. (1) Microvilli. (2) Heterochromatin clumps (arrows) and dilated intercellular spaces
(asterisks). (3) Desmosomes (arrows). (4) Rough endoplasmic reticulum. (5) Golgi complexes. (6) Autophagic vacuoles (asterisk). Scale bars
(from 1 to 6): 0.4 lm, 1 lm, 0.5 lm, 0.5 lm, 0.5 lm and 1 lm.
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sporadic CRC, with APC (5/6) and KRAS mutations
(4/6) (Fig. 5A). Accordingly, nuclear staining of
MLH1, PMS2, MSH2, and MSH6 proteins in all cases
(data not shown) and lack of POLE mutation ruled
out a hypermutated MMR phenotype.
Transcriptomic profiles of untreated normal and
tumor organoids showed a high number of
differentially expressed genes, which mostly coincide
with those previously reported (Fig. 5B; GSE64392)
[14]. Paired analysis of data from normal and tumor
organoids of each patient followed by joint analysis of
all patients’ data revealed that calcitriol significantly
changed the expression of 2,107 genes (943 upregu-
lated, 1,164 downregulated) in normal organoids and
Fig. 4. Antiproliferative action of calcitriol in human normal and tumor organoids. (A) Proliferation assay of normal and tumor organoid
cultures from seven patients treated with 100 nM calcitriol or vehicle for 10 days. Box-plot represents median  max/min. Statistical
analysis was performed by nonparametric Wilcoxon signed-rank test, *P < 0.05, ***P < 0.001. (B) Phase-contrast images of human normal
and tumor organoid cultures from (A). Broken line indicates the border of Matrigel. Scale bars: 1 mm. (C) Graph showing the number of
normal and tumor organoids used in (A) after 10 days of calcitriol treatment. Box-plot represents median  max/min. Statistical analysis was
performed by Wilcoxon signed-rank test. The exact P-values are indicated for nonsignificant results. (D) RT-qPCR analysis of VDR RNA level
in normal and tumor organoids from (A) in relation to that of SW480-ADH colon carcinoma cells. Data are represented as mean  standard
deviation (SD). (E) Scattegram showing the inverse correlation between VDR RNA levels and cell proliferation in organoids used in (A).
Statistical significance was determined by Pearson test.
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1,182 genes (643 upregulated, 539 downregulated) in
tumor organoids, which were partially coincident (532,
19.3%) (Fig. 5C,D and Table S2; GSE100785). A
strong correlation was found between genes induced
by calcitriol in normal and tumor organoids, whereas
the correlation was much weaker for repressed genes
(Fig. 5E). Common calcitriol-target genes in both
types of organoids included known VDR-regulated
genes such as CYP24A1 and TRPV6 (Fig. 5F and
Table S2). Notably, some clusters of genes showed dif-
ferent quantitative or even inverse regulation by cal-
citriol in normal and tumor organoids (Fig. 5G, left).
The expression level of these genes in untreated nor-
mal and tumor organoids is shown (Fig. 5G, right).
Calcitriol targets also included genes involved in a
variety of metabolic, detoxification, nuclear receptor-
related, and other pathways (Table S3). Supporting
post-translational regulation by vitamin D, as
described in several systems [19,20], VDR was not
identified as a significant regulated gene in the RNA-
seq analysis.
Among the top up/downregulated genes by calcitriol
in normal and tumor organoids, there were some
involved in cell stemness (MSI1, SMOC2), differentia-
tion (CEACAM7, HMGCS2, and MUC2), prolifera-
tion (GRK5, RARRES1), and tumorigenesis
(ALDH3A1, S100P) (Table S4). So, next we used an
independent cohort of 18 normal and 9 tumor orga-
noids to a) confirm the effect of calcitriol on the
expression of several genes that were found to be sig-
nificantly regulated in the RNA-seq assay and, b)
study the effect of calcitriol on genes involved in those
processes or pathways relevant for colon biology. As
expected, differentiation genes were expressed at higher
levels in untreated normal than in tumor organoids
(Fig. S2). Interestingly, the opposite was found for
stemness-related genes, which showed lower expression
in untreated normal than in tumor organoids
(Fig. S2). In line with the RNA-seq data, RT-qPCR
analyses confirmed the upregulation by calcitriol of
multiple stemness-related genes including LGR5,
MSI1, PTK7, SMOC2, LRIG1, and MEX3A, a mar-
ker of slow-dividing subpopulation of LGR5+ stem
cells, in normal organoids (Fig. 6A) [9,12,21,22]. In
tumor organoids, the effects of calcitriol on stemness-
related genes were weaker as only MSI1 and LRIG1
were upregulated (Fig. 6A).
Consistent with the ultrastructural analysis, calcitriol
induced desmosomal (DSC2), microvilli (PLS1), and
adhesion (CDH1) genes in tumor organoids
(Table S2). We also confirmed by RT-qPCR that sev-
eral genes expressed in differentiated enterocytes
(KRT20) or in goblet/secretory cells (KLF4, SPDEF,
and MUC2) were downregulated by calcitriol in nor-
mal but not in tumor organoids (Fig. 6A). Addition-
ally, Gene Set Enrichment Analysis (GSEA) showed
that the differentiation signature EPHB2low vs.
EPHB2high of human colon cells [12] was significantly
enriched in calcitriol-treated tumor, but not normal,
organoids (Fig. 6B).
We also observed that a series of genes involved in
cell proliferation (LRIG1, GRK5, RARRES1, TFF2,
and TNS4) and tumorigenesis (ALDH3A1, BCAS1,
S100P, PPP1R14D, and SERPINE1) were regulated
by calcitriol, preferentially in normal organoids, in a
way compatible with the previously described antipro-
liferative action of calcitriol and a potential antitu-
moral effect (Fig. 6A). Concordant with its effects on
cell proliferation, GSEA revealed an inverse associa-
tion of the calcitriol profile (RNA-seq) with E2F,
mTOR, and c-MYC proliferative signatures (Fig. 6C).
GSEA also showed that untreated tumor organoids
were enriched in the ‘Core transcriptional embryonic
stem cell (ESC)-like’ pro-tumorigenic signature that, as
described by Wong and cols [23] is frequently activated
in aggressive human epithelial cancers. Remarkably,
calcitriol was able to abolish this association in both
types of organoids (Fig. 6D). In contrast to data on
Fig. 5. Transcriptomic profile changes by calcitriol in human normal and tumor organoids. (A) Overview of the mutations found in the tumor
organoid cultures of six selected patients. (B) Volcano plot comparing human normal and tumor RNA-seq signatures from the six matched
organoid cultures analyzed in (A). The x-axis shows the fold-change (Log2) and the y-axis shows the q-value (Log2). Each dot represents a
gene. Blue/red dots represent genes that are down- or upregulated (respectively) in tumor vs. normal organoids. Dots above the line are
significant. (C) Volcano plot comparing normal (upper blot) and tumor (lower blot) organoid signatures from (B) treated with 100 nM calcitriol
or vehicle for 96 h. (D) Venn diagram showing the overlap between calcitriol-significant regulated genes in normal and tumor organoids. The
number of genes included in each group is depicted and the complete list of genes is in Table S2. (E) Graphs representing the linear
correlation between the effect of calcitriol on gene expression (left graph, induction; right graph, repression), computed as the ratio (Log10
fold-change) of the RNA-seq counts, in treated organoids over controls. Only genes significantly (FDR<0.05) regulated by the treatment in
normal organoids are represented. Green line, theoretical perfect correlation (r2 = 1). Statistical analysis was performed by Multiple r-
squared regression test. (F) Heatmap showing significant genes commonly regulated by calcitriol in matched normal and tumor organoids
with an average Log2 fold-change > 1 and expression > 4 cpm. (G) Heatmaps showing the genes with the greatest variance between
sample groups of Log2 fold-change upon calcitriol treatment in matched normal and tumor organoids (left) and tumor RNA expression of
those genes compared to its normal counterpart (right).
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carcinoma cell lines cultured in 2D conditions [15], cal-
citriol did not repress classical genes of the Wnt path-
way except DKK4 (Fig. 6A), a gene that increases
invasiveness, angiogenesis, and chemoresistance [24,25]
(Table S5).
To confirm the specificity of the RNA-seq results,
we silenced VDR expression in normal organoids
through lentiviral transduction of a shRNAmir against
VDR, which inhibited the regulation of several cal-
citriol-target genes (Fig. S3). Overall, these results
show that calcitriol has different/opposite regulatory
effects on stemness and differentiation genes in human
normal and tumor organoids.
In addition, we generated colon organoids from
wild-type (wt) and, as control, Vdr-deficient (Vdr/)
mice and analyzed the transcriptomic profile induced
by calcitriol treatment using RNA microarrays. As
expected, no genes were regulated by calcitriol in orga-
noids from Vdr/ mice, while 143 target genes were
identified in wt organoids. Remarkably, only 32 genes
overlapped between those regulated by calcitriol in
human (RNA-seq analysis) and mouse (RNA microar-
rays, GSE105117) colon organoids (Fig. S4A), while
111 genes were exclusively regulated in mouse orga-
noids (Table S6). This result agrees with the reported
lack of conservation of VDR response elements
between primates and rodents [26]. We also show that
the calcitriol expression profile in wt mouse organoids
was related with the Mex3ahigh/Lgr5high mouse signa-
ture of slow-dividing intestinal stem cells [22]
(Fig. S4B).
Identification of direct calcitriol-target genes in
human colon organoids
To further elucidate the action of calcitriol in colon
homeostasis, we searched for direct transcriptional tar-
get genes in normal organoids. To this end, three inde-
pendent chromatin immunoprecipitation-sequencing
(ChIP-seq) assays were performed using six additional
normal patient-derived organoids (2 per ChIP-seq)
treated with calcitriol for 2 h. A variable number of
DNA binding sites for VDR were found after calcitriol
treatment (Fig. 7A). As in other systems [27], a large
number of VDR-binding sites were located in intronic
or intergenic regions (Fig. S5A). Identified peaks were
assigned to the nearest gene at a maximum distance of
10 kb. As many as 559 genes were coincident between
two ChIP-seq assays and 182 genes were coincident in
all three, including CYP24A1 and TRPV6 (Table S7;
GEO107283). Moreover, GSEA revealed that the cal-
citriol-direct target gene signature, defined as the 182
genes commonly identified in all ChIP-seq assays, was
strongly associated with calcitriol-upregulated genes in
the RNA-seq analysis (Fig. 7B). This result agrees
with the current model of VDR/nuclear receptor
action: direct binding to upregulated genes and pre-
dominant indirect action by signaling interference, pro-
tein–protein interaction or via microRNAs on
downregulated genes [28]. Remarkably, 68 genes of the
182-gene signature overlapped with those regulated (62
up- and 6 downregulated) by calcitriol in the RNA-seq
assay (Table S7). The stemness-related MSI1 and
SMOC2 genes, several genes with antiproliferative
and/or tumor suppressive function (KCNIP3,
PPP1R1C, PRKG2, PRR5L, GRK5, and RARRES1,
the latter with a VDR-binding site 37 kb away from
50UTR), and CYP24A1 and TRPV6 (Fig. 7C) were
among the calcitriol-direct transcriptional targets
(Table S7). ChIP-seq assays also showed enrichment in
the consensus direct repeat (DR)3 VDR motif
(Fig. 7D). The comparison of our RNA-seq data anal-
ysis with public transcription factor (TF) ChIP-seq
datasets confirmed VDR as the most significant TF
involved in gene upregulation (Fig. S5B).
Discussion
The association of vitamin D deficiency with the risk
and severity of clinically relevant gut diseases such as
IBD and CRC, together with the observation that cal-
citriol induces a more differentiated phenotype of ente-
rocytes in vivo and of colon carcinoma cells in 2D
culture conditions [1,3,15], led us to analyze the effects
of calcitriol on human organoids. These 3D structures
constitute the state-of-the-art system to study normal
Fig. 6. Calcitriol distinctly changes gene expression profile of human normal and tumor organoids. (A) RT-qPCR analysis of the RNA level of
selected genes in an independent series of 18 normal and nine tumor organoid cultures treated with 100 nM calcitriol or vehicle for 96 h.
Box plots represent median  max/min. Statistical analysis was performed by One-sample t-test (normal organoids) and nonparametric
Wilcoxon signed-rank test (tumor organoids), *P < 0.05, **P < 0.01, ***P < 0.001. The exact P-values are indicated for nonsignificant
results. (B) GSEA comparing the reported human healthy colon EPHB2-based differentiation gene signature and the RNA-seq analysis of
human tumor colon organoids treated with calcitriol. (C) GSEA comparing the proliferation-related molecular signatures databases and the
RNA-seq analyses of human normal and tumor organoids treated with calcitriol. (D) GSEA comparing the pro-tumorigenic signature core
ESC-like with the RNA-seq analysis of genes up/downregulated in tumor vs. normal organoids (upper graph), and with that of normal or
tumor organoids treated with calcitriol (lower graphs).
63The FEBS Journal 287 (2020) 53–72 ª 2019 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of
Federation of European Biochemical Societies.
A. Fernandez-Barral et al. Vitamin D regulates human colon stem cells
64 The FEBS Journal 287 (2020) 53–72 ª 2019 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of
Federation of European Biochemical Societies.
Vitamin D regulates human colon stem cells A. Fernandez-Barral et al.
and tumoral epithelial stem cells in vitro. We report
unanticipated differential effects of calcitriol on both
types of organoids that are relevant for understanding
the relevance of vitamin D in normal and pathological
intestinal biology.
Vitamin D action in human colon has classically
been investigated in immortalized carcinoma cell lines,
and recently in ex vivo short-lived colon biopsy sam-
ples and primary fibroblasts from patient-derived nor-
mal and tumor tissue [29,30]. We report for the first
time that human colon stem cells express VDR in vivo.
VDR is a major determinant of tissue responsiveness
to vitamin D. Others are the circulating level of the
liver-synthesized calcitriol precursor 25-hydroxyvitamin
D/calcidiol, the activity of CYP27B1 and CYP24A1
enzymes that synthesize and degrade calcitriol, respec-
tively, and the nuclear expression of VDR co-repres-
sors and co-activators [2,3]. This finding points to a
potential effect of calcitriol on the behavior of normal
and cancer stem cells.
To directly address these issues, we established a
unique long-term culture collection of matched
patient-derived normal and tumor organoids and
tested the effects of calcitriol. First, we validated that
VDR is co-expressed in vivo with LGR5 and PTK7,
markers of colon crypt base columnar stem cells, and
furthermore, it mediates in normal organoids the
induction of LGR5 by calcitriol. The direct binding of
VDR to, and transcriptional regulation of, other stem-
ness-related genes such as MSI1 and SMOC2 in nor-
mal organoids further supports the stemness-inducing
action of calcitriol in colon tissue. Together, these
results strengthen the association of the vitamin D-in-
duced gene expression program with the maintenance
of stemness of, perhaps, several colon stem cell popu-
lations. Homeostasis of intestinal mucosa, one of the
tissues with the highest cell renewal, depends on an
adequate balance between proliferation and differentia-
tion of crypt bottom stem cells and their progeny in
response to a number of intrinsic and stromal signals
such as Wnt, EGF, Notch, Hippo, BMP, and Hedge-
hog. The new actions of vitamin D described in this
study may contribute to the homeostasis of healthy
intestinal mucosa, and to the repair and regeneration
of damaged intestine upon injury. In line with this,
epidemiological studies indicate an association of vita-
min D deficiency with IBD, and experiments with ani-
mal models suggest a beneficial effect of VDR agonists
in these conditions [31].
We also determined that calcitriol declines, but does
not abolish, cell proliferation in normal organoids.
Although Wnt and EGF pathways are essential for
colon stem cell proliferation in vivo and, concordantly,
for the generation of organoids in vitro [32,33], we
show that calcitriol reduces cell proliferation in normal
organoids, yet classical Wnt pathway genes were unaf-
fected in our transcriptomic analyses. Instead, cal-
citriol upregulates LRIG1, marker of quiescent + 4
stem cells [21,31] and also master regulator of epithe-
lial stem cells and tumor suppressor that encodes a
multilevel tyrosine kinase receptor (EGFR and others)
inhibitor [34,35]. Moreover, we observed in mouse,
due the lack of the equivalent human signature, that
calcitriol induces a gene expression profile that is
related to the Mex3ahigh/Lgr5high signature of slow-di-
viding intestinal stem cells [22]. Additionally, calcitriol
inhibits the activator of EGF pathway TFF2 gene [36]
and regulates the expression of the pro-tumorigenic
gene TNS4 and of the negative regulators of colon car-
cinoma cell proliferation RARRES1 (also known as
TIG1) and its target GRK5 [37]. Conceivably, these
effects may contribute to the antiproliferative action of
calcitriol in crypt stem cells.
Our results show that the gene regulation effect of
calcitriol is much stronger in human than in mouse
colon organoids, and that little coincidence exists
between target genes in the two species. However,
Peregrina and collaborators reported the presence of
Vdr and a role of dietary vitamin D in the growth and
maturation of mouse intestinal Lgr5+ cells [38].
The finding that calcitriol has pro-differentiation and
variable antiproliferative effects lacking stemness induc-
tion in tumor organoids adds to the reported actions on
carcinoma cell lines and cancer-associated fibroblasts,
which indicates that calcitriol is a multifaceted protec-
tive agent against CRC. In line with the cancer stem cell
model stating that tumors originate from the mutational
alteration of resident tissue stem cells, human CRC is
mainly supported by mutated LGR5+ stem cells [39].
The pro-differentiation effect of calcitriol on tumor
Fig. 7. Direct transcriptional calcitriol-target genes in human colon normal organoids. (A) Venn diagram showing the overlap between genes
with VDR binding sites identified by ChIP-seq in three independent experiments using six human normal organoid cultures treated with
100 nM calcitriol for 2 h. (B) GSEA comparing the genes containing VDR-binding sites identified in the ChIP-seq assays and those regulated
by calcitriol in normal organoids in the RNA-seq analysis. (C) Integrative Genome Visualization (IGV) representation of VDR-binding sites
identified in the ChIP-seq assays in CYP24A1 and TRPV6 (controls), MSI1, GRK5, SMOC2, and RARRES1 genes. (D) Homer de novo motif
analysis of VDR-binding sites in ChIP-seq studies. (E) Scheme showing the proposed action of vitamin D on normal and cancer colon stem
cells.
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organoid cells is in line, albeit less apparent, with that
observed in colon carcinoma cell lines grown on plastic
dishes [15]. Notably, VDR agonists have been proposed
to promote terminal differentiation of normal upper
crypt absorptive enterocytes [1], which however is not
observed in cells of normal colon organoids. This dis-
crepancy may rely on differences in the microenviron-
ment (location and other signals) and the distinct
phenotype of these two cell populations (top crypt ente-
rocytes/bottom crypt stem cells) in human tissue and
organoid culture, respectively. In this scenario, our
results favor a protective action of VDR agonists
against CRC. Further supporting this we describe that
calcitriol downregulates a gene signature associated to
aggressiveness and poor prognosis of breast and lung
carcinoma patients [23].
In summary, the newly identified functions in
patient-derived organoids reveal an unanticipated
homeostatic action of vitamin D in the human intesti-
nal mucosa. This strongly supports a role of calcitriol
in the maintenance of colon crypt cell stemness and in
the differentiation of colon cancer stem cells (Fig. 7E).
Materials and methods
Human samples
Fresh human tissues were provided by IdiPAZ and Fun-
dacion Jimenez Dıaz Biobanks, integrated into the Spanish
Biobank Network ( www.redbiobancos.es), from individu-
als diagnosed with colorectal cancer and subjected to sur-
gery between 2013 and 2018. Normal tissue samples were
obtained from the area distal to the tumor and the histol-
ogy of the biopsies was evaluated by the pathology services
of La Paz University Hospital and Fundacion Jimenez
Dıaz. All human subjects gave informed consent. The study
complied with ethical regulations and was approved by the
Ethics Committee of La Paz University Hospital (HULP-
PI-1425) and the Fundacion Jimenez Dıaz (PIC-15/2014).
Establishment of 3D colon and tumor organoid
cultures
To establish human normal colon organoids, colon crypts
were isolated from human biopsies as previously described
[10,11]. Briefly, colon mucosa biopsies were incubated with a
mixture of antibiotics [Primocin (Invivogen, San Diego, CA,
USA), Gentamycin and Fungizone (Thermo Fisher Scien-
tific, MA, USA)] for 30 min in rotation at room temperature
(RT). Next, tissue was cut into small pieces and incubated
twice with 10 mM dithiothreitol (DTT) for 5 min at RT.
Samples were then transferred to 8 mM EDTA solution for
5 min at RT and 60 min in slow rotation at 4 °C. Samples
were washed in PBS until complete EDTA removal and
transferred to a 50 mL conical tube in fresh PBS. Colon
crypts were separated from the mucosa after shaking and
supernatant was centrifuged at 115 g for 5 min at RT. Crypts
were washed twice in washing buffer [Advanced DMEM/
F12, 10 mM HEPES, and 10 mM Glutamax (Thermo Fisher
Scientific)] and finally pelleted crypts were embedded in
Matrigel (Corning, MA, USA). Drops were seeded on pre-
warmed, 48-well culture dishes. After Matrigel solidification
at 37 °C complete ‘normal’ culture medium was added [50%
Advanced DMEM/F12, 50% Wnt3a-conditioned medium,
10 mM HEPES, 10 mM Glutamax, 10 mM Nicotinamide
(Sigma-Aldrich, St. Louis, MD, USA), 1x N2 (Thermo
Fisher Scientific), 1x B27 (Thermo Fisher Scientific), 1 mM
N-acetyl-L-cysteine (Sigma-Aldrich), 1 : 500 Primocin,
0.1 lgmL1 Noggin ( Peprotech, New Jersey, NJ, USA),
1 lgmL1 Gastrin (Tocris, Bristol, UK), 1 lgmL1 RSPO1
(Sinobiological, Beijing, China), 50 ngmL1 EGF (Pepro-
tech), 0.02 lM PGE2 (Sigma-Aldrich), 1 lM LY-2157299
(Axon-Medchem, Groningen, The Netherlands), and 10 lM
SB-202190 (Sigma-Aldrich)].
To establish mouse normal colon organoids, colon crypts
were basically isolated as described for human crypts with
minor modifications. Mouse colon was washed in PBS,
incubated for 30 min with antibiotics (Primocin) and cut
into small pieces. Next, tissue was incubated for 5 min with
8 mM EDTA at RT and 30 min at 4 °C in slow rotation.
Then, it was washed in PBS to remove EDTA. Crypts were
isolated after shaking and collected in a 50 mL conical tube
after passing the solution through a 70-lm mesh filter. The
crypts solution was centrifuged at 260 g for 5 min at 4 °C.
The pellet was washed in washing buffer and pelleted
crypts were embedded in Matrigel on a prewarmed 48-well
culture dish. After Matrigel solidification, ‘mouse’ culture
medium was added (‘normal’ culture medium minus Nicoti-
namide, Gastrin, PGE2, and SB-202190).
Human tumor organoid cultures were generated as fol-
lows. Human tumor biopsies were washed in PBS several
times and incubated in a mixture of antibiotics (Primocin,
Gentamycin, and Fungizone) for 30 min in rotation at RT.
To obtain single cells, tissue was cut into small pieces and
digested enzymatically in a suspension of 1 mgmL1 colla-
genase type IV (Sigma-Aldrich) (in PBS) for 30 min at
37 °C with continuous shaking in a waterbath. We forced
cell disaggregation by passing the suspension through a
18G syringe. Next, we added 5% FBS and single cells were
collected in a conical 50 mL tube after passing the solution
through a 70-lm mesh filter and centrifugation at 250 g for
5 min at 4 °C. To lyse erythrocytes, the pellet obtained
after centrifugation was incubated in 157 mM NH4Cl for
5 min, washed in PBS and centrifuged again. Cells were
then washed in washing buffer and finally pelleted cells
were embedded in Matrigel and seeded on prewarmed 48-
well culture dishes. After Matrigel solidification, ‘tumor’
culture medium was added (‘normal’ culture medium minus
Wnt3a-conditioned medium, Nicotinamide and RSPO1).
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Growth and expansion of organoid cultures
Normal and tumor culture medium was changed every
other day. For passaging, we followed the protocol
described [10,11], with modifications. Briefly, Matrigel-em-
bedded organoids were collected using a scraper in a
15 mL conical tube and incubated with Cell Recovery
Solution (Corning) for 30 min on ice with continuous shak-
ing to remove Matrigel. After centrifugation at 260 g 5 min
at 4 °C, organoids were washed in washing buffer and cen-
trifuged again. Next, organoids were incubated with disag-
gregation buffer [washing buffer solution containing
1 mgmL1 dispase (Thermo Fisher Scientific)] for 10 min
at RT in orbital rotation. Immediately afterwards, 2 mM
EDTA was added and the mixture was incubated for an
additional 5 min. Following this, the solution was homoge-
nized by passing it through a 21G syringe, collected in a
15 mL conical tube, centrifuged at 250 g for 5 min at 4 °C
and washed twice in washing buffer. Pelleted cells were
embedded in Matrigel and seeded on culture dishes.
RNAscope in situ hybridization
In situ hybridization for LGR5 on formalin-fixed paraffin-
embedded samples (colon mucosa and normal/tumor orga-
noids) was performed using the RNAscope 2.5 HD Assay-
RED (Advanced Cell Diagnostics; External Service, Dr. Ilse
Rooman’s laboratory at Vrije Universiteit Brussel) according
to manufacturer’s instructions and with standard sample pre-
treatment (15 min Target Retrieval and 30 min Protease
Plus). Subsequently, sections were stained for VDR using a
rabbit monoclonal antibody (D2K6W #12550, Cell Signal-
ing, Danvers, MA, USA) diluted 1:50 in Antibody Diluent
(Agilent, Santa Clara, CA, USA) and applied for 20 min at
RT. For detection, a donkey anti-rabbit Alexa Fluor 488-la-
beled F(ab’)2 secondary antibody (Jackson ImmunoResearch
Europe, Cambridgeshire, UK) was used, diluted 1:500 in
PBS and applied for 30 min at RT. Nuclei were counter-
stained with Hoechst 33342. Images were taken with Zeiss
LSM710 confocal microscope (Zeiss, Oberkochen, Ger-
many). VDR and LGR5 colors were changed using IMAGEJ
software for a better visualization (VDR in red and LGR5 in
green). Images of at least 25 crypts/patient from four patients
were taken in a confocal microscope. Quantification of VDR
and LGR5 staining was performed manually by two people,
considering the percentage of positive cells from a total of 46
cells of the crypt bottom per crypt.
Western blot
Normal (passages 1–5) and tumor (passages 3–8) organoids
were pelleted after removing Matrigel with Cell Recovery
Solution and whole-cell extracts were prepared using RIPA
buffer (0.05 M Tris/HCl pH 7.5, 0.1% SDS, 0.15 M NaCl,
1% Triton X-100 (Sigma-Aldrich) and 1% sodium
deoxycholate) containing protease and phosphatase inhibi-
tors (10 lgmL1 leupeptin, 10 lgmL1 aprotinin, 1 mM
PMSF, 1 mM orthovanadate, and 1 mM NaF, all from
Sigma-Aldrich). Cell extracts were separated by SDS/
PAGE, transferred to PVDF membranes and incubated
with the following primary antibodies: rabbit monoclonal-
VDR (D2K6W) (Cell Signaling, #12550), rabbit polyclonal-
CA2 (CUSABIO, #PA004370HA01HU, TX, USA), rabbit
polyclonal-CYP24A1 (Santa Cruz Biotechnology, #sc-
66851, Dallas, TX, USA) and goat polyclonal-b-actin
(Santa Cruz Biotechnologies, #sc-1616). Different exposure
times of the films were used to ensure that bands were not
saturated. ImageJ was used for the semi-quantification of
VDR protein level.
Electron microscopy
For electron microscopy analysis, samples from three human
normal (patients #11, #12, and #37; passages 2–11) and
tumor organoid cultures (patients #4, #29, and #38; passages
10–21) treated with 100 nM calcitriol or vehicle for 96 h
(n = 3 per group) were fixed with 3% glutaraldehyde (Mer-
ck-Millipore, Burlington, MA, USA) in 0.12 M phosphate
buffer, pH 7.4. Samples were then rinsed in 0.12 M phos-
phate buffer, postfixed in 2% osmium tetroxide (Sigma-
Aldrich), dehydrated in acetone and embedded in araldite
(Durcupan, Sigma-Aldrich, St. Louis, MO, USA). Ultrathin
sections stained with uranyl acetate and lead citrate were
examined with a JEOL 201 electron microscope.
Proliferation and clonogenicity assays
Normal (passages 2–7) and tumor (passages 8–27) organoids
were disaggregated with 1 mgmL1 dispase and around
6000–7000 single cells were seeded on 20 lL Matrigel drops
in 48-well culture dishes. Organoids were incubated with nor-
mal or tumor complete medium plus Y-27632 (Tocris) in the
presence of 100 nM calcitriol or vehicle for 10 days. Medium
and calcitriol/vehicle were replaced every other day. At day
10, normal and tumor organoids were used to study RNA
expression and cell viability by estimating the amount of cel-
lular ATP using the CellTiter-Glo Luminescent Cell Viability
Assay (Promega, Madison, WI, USA) following the manufac-
turer’s instructions. To analyze the clonogenicity, pictures of
drops were taken at days 0 and 10 of the cell viability assay
and the number of organoids in each drop was counted using
MIPAR software [40]. Phase-contrast images of cultured orga-
noids were captured with a DFC550 digital camera (Leica,
Wetzlar, Germany) mounted on an inverted TS100 micro-
scope (Nikon, Tokio, Japan).
Mutational status
Mutations present in six tumor organoid cultures from
CRC patients (#1–6; passages 1–3) were analysed. Briefly,
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Matrigel was removed using ice-cold Cell Recovery follow-
ing manufacturer’s instructions and DNA was extracted
from pelleted organoids by incubation overnight (O/N) at
56 °C with lysis buffer [50 mM Tris/HCl pH 8.0, 100 mM
EDTA pH 8, 100 mM NaCl, 1% SDS, and 20 mgmL1
proteinase K (Merck-Millipore, MA, USA)]. Saturated
NaCl buffer was added for 5 min and DNA was precipi-
tated with isopropanol and washed twice with 70% etha-
nol. DNA was genotyped by sequencing the amplified
product of a multiplexed-PCR reaction (Amplicon sequenc-
ing) using a proof-reading polymerase. Indexed libraries
were pooled and loaded onto a MiSeq instrument (Illu-
mina). Initial alignment was performed with BWA after
primer sequence clipping and variant calling was done with
the GATK Unified Genotyper and VarScan2 followed by
ANNOVAR annotation. Mutations were called at a mini-
mum 3% allele frequency. SNPs were filtered out with
dbSNP and 1000 genome datasets. All detected variants
were manually revised and confirmed.
Real-time quantitative PCR
Matrigel-embedded normal and tumor organoids (passages 1–6)
were washed twice in PBS, lysed with TRIZOL (Thermo Fisher
Scientific) and total RNA was purified using the NucleoSpin
miRNA extraction kit (Machery-Nagel, D€uren, Germany). For
cDNA retrotranscription iScript cDNA Synthesis kit, (Bio-Rad,
Hercules, CA, USA) was used. RT-qPCR analyses were per-
formed with the TaqmanUniversal PCRMaster Mix (Applied
Biosystems, Waltham, CA, USA) using the following
FAM-labeled TaqMan probes (Applied Biosystems):
ALDH3A1 (Hs00964880_m1), AXIN2 (Hs00610344_m1),
BCAS1 (Hs00180227_m1), CA2 (Hs01070108_m1), CCND1
(Hs00765553_m1), CEACAM7 (Hs00185152_m1), CYP
24A1 (Hs00167999_m1), DKK1 (Hs00183740_m1), DKK4
(Hs00205290_m1), GRK5 (Hs00992173), HMGCS2
(Hs00985427_m1), IFITM1 (Hs01652522_g1), IFITM2 (Hs0
0829485_sH), JSRP1 (Hs00376079_m1), KLF4 (Hs0035883
6_m1), KRT20 (Hs00300643_m1), LGR5 (Hs00173664_m1),
LRIG1 (Hs00394267_m1), MSI1 (Hs01045894_m1), MUC2
(Hs03005103_g1), MYC (Hs00153408_m1), PPP1R14D (Hs
00214613_m1), RARRES1 (Hs00161204_m1), S100P (Hs00
195584_m1), SERPINE1 (Hs01126606_m1), SLC2A1 (Hs00
892681_m1), SMOC2 (Hs00405777_m1), SPDEF (Hs0102
6050_m1), TFF2 (Hs00193719_m1), and TNS4 (Hs0026266
2_m1). RNA expression values were normalized vs the VIC-
labeled TaqMan probe for housekeeping gene large riboso-
mal protein (RPLPO) (H99999902_m1) using the compara-
tive CT method. Additionally, we used Power SYBR
 Green
PCR Master Mix (Applied Biosystems) and the following pri-
mers to VDR (forward 50 AACGCTGTGTGGACAT
CGGC-30; reverse 50-GTCATGGCTTTCGTTGGACT-30),
MEX3A (forward 50-CAAGCTCTGCGCTCTCTACA-30;
reverse 50-ATGAACACTGGTTCCTCGCC-30) and PTK7
(forward 50-TCTGGGAGACCTCAAGCAGT-30; reverse 50-
ATGCACAAAGCGGTTGTTGG-30) analysis, and their val-
ues were normalized vs. the housekeeping gene Succinate Dehy-
drogenase Complex subunit A (SDHA) (forward 50-TG
GGAACAAGAGGGCATCTG-30; reverse 50-CCACCACT
GCATCAAATTCATG-30) using the comparative CT method.
All RT-qPCR were performed in a CFX384 Touch Real-Time
PCRDetection System (Bio-Rad). SW480-ADHcells were used
as relative value to compare VDR and CYP24A1 expression in
Figs 2A,B and 4D. To study the mRNA levels of other genes,
organoids treated with vehicle were used as control.
RNA-sequencing
Matched normal and tumor organoids from six patients (#1–
6; passages 1–3) were seeded in 48-well culture dishes and
48 h later were treated with 100 nM calcitriol (Sigma-
Aldrich) or vehicle for 96 h. Medium and calcitriol/vehicle
was replaced every other day. Total RNA was extracted and
RNA integrity was confirmed as optimal for all samples on
an Agilent 2100 Bioanalyzer (RIN range 9.1–9.9). Six hun-
dred nanograms of RNA samples was used for library con-
struction. PolyA+ fraction was purified and randomly
fragmented, converted to double stranded cDNA and pro-
cessed through subsequent enzymatic treatments of end-re-
pair, dA-tailing and ligation to adapters as in Illumina’s
TruSeq Stranded mRNA Sample Preparation kit (Illumina,
CA, USA). Adapter-ligated library was completed by PCR
with Illumina PE primers (eight cycles). The resulting puri-
fied cDNA library was applied to an Illumina flow cell for
cluster generation and sequenced on an Ilumina HiSeq2000
by following manufacturer’s protocols. Eight samples were
combined per sequencing lane and a minimum of 25 million
50 base single-reads were generated for each sample.
Sequencing reads were aligned to the transcriptome with
TopHat2 [41]. Novel transcript discovery was not
attempted. TopHat was provided with known gene annota-
tions and other transcript data obtained from Gencode
(Version 26 – Ensembl 75) basic gene set for the GRCh37/
hg19 human genome assembly [42]. Gene expression level
was calculated from TopHat alignments as the number of
reads per gene computed using HTSeq [43] using default
settings and gene features as defined in the GRCh37.75
release of the human genome (gtf file). Differential gene
expression analysis was performed with the Bioconductor
[44] DEseq2 package for the R statistical Software [45]. Sin-
gle enrichment analysis was performed with differentially
expressed genes between calcitriol vs. vehicle treatment. The
analysis was carried out with the functional annotation tool
included in the PathVisio bioinformatic resources [46,47].
Chromatin immunoprecipitation-sequencing
We performed three independent ChIP-seq experiments with
human normal organoids (two culture organoids/experi-
ment: ChIP #1, patients #34&35 at passages 12 and 6; ChIP
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#2, patients #18&19 at passages 3 and 4; and ChIP #3,
patients #38&39 at passages 2 and 4) following the ChIP-seq
Millipore protocol with modifications. Briefly, normal orga-
noids from two patients cultured on 6-well dishes were trea-
ted with 100 nM calcitriol or vehicle for 2 h. DNA-protein
crosslinking was done by incubation of Matrigel-embedded
organoids with 1% formaldehyde (methanol free) for 8 min
shaking at 4 °C. Crosslinking was quenched with 1.25 mM
glycine in PBS for 5 min. We transferred the organoid solu-
tion to a 50 mL conical tube for centrifugation at 700 g for
5 min at 4 °C. Supernatant was removed and the pellet was
washed twice in cold PBS, transferred to a 1.5 mL tube and
lysed in 1 mL ChIP-lysis buffer [1% SDS, 10 mM EDTA,
50 mM Tris/HCl pH 8.1 and 1x protease cocktail inhibitors
(Complete, EDTA-free, Sigma-Aldrich)] for 1 h. We used a
21G syringe to homogenize the solution and force the lysis.
Samples were sonicated for 20 min at maximum intensity at
4 °C in a S220 Focused-ultrasonicator (Covaris). We took
40 lL of calcitriol and vehicle-samples as input control, and
diluted 10-fold the remaining sonicated cell supernatant in
ChIP-dilution buffer (0.01% SDS, 1.1% Triton X-100,
1.2 mM EDTA, 167 mM NaCl, Tris/HCl pH 8.1 and 1x pro-
tease cocktail inhibitor). After 45 min precleaning incubation
using magnetic beads (Magna ChIPTM Protein A+G Mag-
netic Beads, Merck-Millipore), the supernatant was incu-
bated with 10 lg rabbit monoclonal-VDR (D2K6W)
antibody (Cell Signaling #12550, 2 mgmL1, made to order)
O/N in orbital rotation at 4 °C. Immunocomplexes were
recovered using magnetic beads for 2 h in orbital rotation at
4 °C. Immunoprecipitated material was then washed in the
following buffers in the indicated order: ChIP-dilution buf-
fer, ChIP-low salt buffer (0.1% SDS, 1% Triton X-100,
2 mM EDTA, 150 mM NaCl, 20 mM Tris/HCl pH 8.0 and 1x
protease cocktail inhibitor), ChIP-high salt buffer (0.1%
SDS, 1% Triton X-100, 2 mM EDTA, 500 mM NaCl, 20 mM
Tris/HCl pH 8 and 1x protease cocktail inhibitor), ChIP-
LiCl buffer (0.25 M LiCl, 1% NP-40, 1% sodium deoxy-
cholate, 1 mM EDTA, 10 mM Tris/HCl pH 8.0 and 1x pro-
tease cocktail inhibitor), ChIP-TE buffer (two washes) and
finally eluted in freshly prepared ChIP-elution buffer (1%
SDS, 0.1 M NaHCO3). The eluted solution and input con-
trols were incubated with 0.2 M NaCl at 65 °C ON in order
to de-crosslink the DNA complexes, and subsequently we
added 9.5 mM EDTA, 36.5 mM Tris/HCl pH 6.5 and
70 lgmL1 proteinase K for 1 h at 45 °C. DNA extraction
was performed using the QIAquick PCR purification kit
(Qiagen, Venlo, The Netherlands).
Fragmented DNA were processed through subsequent
enzymatic treatments of end-repair, dA-tailing, and ligation
to adapters with NEBNext Ultra II DNA Library Prep Kit
for Illumina (New England BioLabs, Ipswich, MA, USA).
Adapter-ligated libraries were completed by limited-cycle
PCR and extracted with a (single) double-sided SPRI size
selection. Median fragment size is 340 bp from which 120 bp
correspond to adaptor sequences. Libraries were applied to
an Illumina flow cell for cluster generation and sequenced on
an Illumina instrument by following manufacturer’s proto-
cols. Sequencing reads were aligned to the GRCh37/hg19 gen-
ome assembly with Bowtie2 [48]. Enriched peak calling was
performed with MACS2 [49] callpeak function, with –q-value
0.15, –nomodel and –extsize 200 options using as control con-
catenated same-patient alignment files from input treated
(calcitriol) and untreated (vehicle). MACS2 bdgdiff function
was used to obtain statistically enriched DNA regions using
the pileup data obtained from the peak calling. Peaks annota-
tion was performed using custom parameters in order to
assign the peaks to the nearest gene in a range of 10 kb
upstream/downstream from the gene body. Manual inspec-
tion of data and RNA-seq identified genes of interest was per-
formed using INTEGRATIVE GENOME VISUALIZATION (IGV) Tool
v.2.3.79 [50,51].
Functional enrichment analysis
We used Gene Set Enrichment Analysis (GSEA) [52] to
assess the degree of association between our RNA-seq pro-
file (genes regulated by calcitriol in human colon normal/
tumor organoids), or microarray expression (genes regu-
lated by calcitriol in mouse colon normal organoids), with
other signatures defined with genes enriched (differentiation
gene set: EPHB2low vs. EPHB2high human normal colon
epithelial cells [12]; proliferation gene sets: E2F, MYC and
mTORC1 hallmark gene sets from MSigDB; pro-tumori-
genic gene set: Core ESC-like from MSigDB; slow-dividing
mouse intestinal stem cells gen set: Mex3ahigh/Lgr5high
mouse colon cells [22] and VDR ChIP-seq in human colon
normal organoids, Table S7). The over-representation of
transcription factor binding sites in genes regulated by cal-
citriol was computed with the Bioconductor TFEA.ChIP
package.
Statistical analysis
Statistical analysis was performed using GraphPad Prism
(GraphPad, CA, USA). P-values < 0.05 were considered sig-
nificant and * indicates P < 0.05, **P < 0.01, and
***P < 0.001. The exact P-values are indicated for nonsignifi-
cant results. Box plots shown in Figs 2A,B, 4A,C and 6A rep-
resent median  max/min. Graphs showing the
quantification of VDR and LGR5 positive cells in human
crypts (Fig. 1B) represent mean  standard error of the
mean (SEM). Graphs showing the RNA levels in VDR inter-
ference (Fig. S3), and relative VDR RNA levels of normal
and tumor organoids (Fig. 4D) represent mean  standard
deviation (SD).
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